|
|
||||||||
Published online before print March 29, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

* Cardiovascular Research Unit and
Department of Hematology, University of Cape Town, Cape Town, South Africa
1 Correspondence: Cardiovascular Research Unit, Chris Barnard Building, University of Cape Town Medical School, Anzio Road, Observatory, 7925, Cape Town, South Africa. E-mail: neil.davies{at}uct.ac.za
Angiopoietin-2 (Ang-2) is a growth factor, which was identified originally as playing a critical role in vessel remodeling during angiogenesis. More recent evidence has indicated additional involvement in vascular homeostatic responses such as coagulation and inflammation, which are central to wound healing. We therefore determined whether a relationship existed between Ang-2 and monocytes, one of the initial cell types to be recruited to a wound, in the context of fibrin clot invasion. Ang-2 significantly increased monocyte invasion of fibrin in the presence of serum. In the absence of serum, it required a combination of Ang-2 and platelet-derived growth factor BB (PDGF-BB) to increase invasion by threefold. Furthermore, it was shown that the heightened invasion was dependent on serine proteases and matrix metalloproteinases (MMPs) and that the combination of Ang-2 and PDGF-BB increased urokinase plasminogen-activator receptor expression, as well as MMP-9 and membrane type 1 MMP expression. These data give further credence to the concept of Ang-2 as a key regulator of several essential phases of wound healing.
Key Words: wound healing proteases matrix metalloproteinases invasion
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |